These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 19920896

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of efficacy of tuberculosis drugs with Immunoxel (Dzherelo) in HIV-infected patients with active pulmonary tuberculosis.
    Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Vihrova LA, Pylypchuk VS, Frolov VM, Kutsyna GA.
    Immunotherapy; 2009 Jul; 1(4):549-56. PubMed ID: 20635986
    [Abstract] [Full Text] [Related]

  • 5. Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin.
    Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA.
    Cytokine; 2008 Dec; 44(3):392-6. PubMed ID: 19027322
    [Abstract] [Full Text] [Related]

  • 6. Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo.
    Zaitzeva SI, Matveeva SL, Gerasimova TG, Pashkov YN, Butov DA, Pylypchuk VS, Frolov VM, Kutsyna GA.
    Clin Microbiol Infect; 2009 Dec; 15(12):1154-62. PubMed ID: 19456829
    [Abstract] [Full Text] [Related]

  • 7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U, Butov DO, Kutsyna GA, Damdinpurev N, Grinishina EA, Mijiddorj O, Kovolev ME, Baasanjav K, Butova TS, Sandagdorj M, Batbold O, Tseveendorj A, Chunt E, Zaitzeva SI, Stepanenko HL, Makeeva NI, Mospan IV, Pylypchuk VS, Rowe JL, Nyasulu P, Jirathitikal V, Bain AI, Tarakanovskaya MG, Bourinbaiar AS.
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
    Wondmagegn T, Damtie D, Genetu M, Biadgo B, Lemma M, Negash M.
    BMC Infect Dis; 2020 Feb 07; 20(1):109. PubMed ID: 32033581
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
    Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh Kumar S, Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi NP, Bhavani PK, Ponnuraja C, Dilip M, Ramachandran R.
    Clin Infect Dis; 2011 Oct 07; 53(7):716-24. PubMed ID: 21890776
    [Abstract] [Full Text] [Related]

  • 16. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
    Wejse C, Furtado A, Camara C, Lüneborg-Nielsen M, Sodemann M, Gerstoft J, Katzenstein TL.
    Int J Infect Dis; 2013 Oct 07; 17(10):e907-12. PubMed ID: 23816410
    [Abstract] [Full Text] [Related]

  • 17. Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
    Hanna LE, Nayak K, Subramanyam S, Venkatesan P, Narayanan PR, Swaminathan S.
    Indian J Med Res; 2009 May 07; 129(5):548-54. PubMed ID: 19675383
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, Padmapriyadarsini C, Ramachandran R, Chinnaiyan P, Suhadev M, Sakthivel R, Narayanan PR.
    Am J Respir Crit Care Med; 2010 Apr 01; 181(7):743-51. PubMed ID: 19965813
    [Abstract] [Full Text] [Related]

  • 20. Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.
    Sinha S, Gupta K, Tripathy S, Dhooria S, Ranjan S, Pandey RM.
    BMC Infect Dis; 2017 Dec 11; 17(1):761. PubMed ID: 29228918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.